losartan and benidipine

losartan has been researched along with benidipine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furuta, K; Hongo, M; Ishizaka, N; Koike, K; Matsuzaki, G; Nagai, R; Saito, K; Sakurai, R1
Furuta, K; Hongo, M; Ishizaka, N; Koike, K; Matsuzaki, G; Nagai, R; Saito, K; Sakamoto, A; Sakurai, R1
Baek, SH; Chae, SC; Cho, MC; Choi, DJ; Ha, JW; Ihm, SH; Jeon, HK; Kim, DS; Kim, KH; Kim, KS; Lim, DS1

Trials

1 trial(s) available for losartan and benidipine

ArticleYear
Benidipine has effects similar to losartan on the central blood pressure and arterial stiffness in mild to moderate essential hypertension.
    Chinese medical journal, 2013, Volume: 126, Issue:11

    Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Essential Hypertension; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Vascular Stiffness

2013

Other Studies

2 other study(ies) available for losartan and benidipine

ArticleYear
Comparison of vasculoprotective effects of benidipine and losartan in a rat model of metabolic syndrome.
    European journal of pharmacology, 2008, Jun-10, Volume: 587, Issue:1-3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Fibrosis; Heart; In Vitro Techniques; Losartan; Metabolic Syndrome; Muscle Relaxation; Myocardium; Nitrates; Nitrites; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2008
Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:3

    Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Channel Blockers; Carnitine O-Palmitoyltransferase; Cholesterol; Dihydropyridines; Disease Models, Animal; Kidney; Lipid Metabolism; Losartan; Male; Metabolic Syndrome; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Superoxides; Triglycerides

2010